Information Provided By: 
Fly News Breaks for October 21, 2015
ILMN
Oct 21, 2015 | 07:51 EDT
Canaccord lowered its price target on Illumina to $205 from $250 following Q3 results. The firm noted results were in-line with the company's pre-announcement, which also included soft Q4 guidance. Canaccord reiterated its Buy rating, as they believe its high-throughput sequencing should keep Illumina well positioned.
News For ILMN From the Last 2 Days
There are no results for your query ILMN
